Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (91-100 of 298) with videos related to

Pageof 30
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 2, 2003
Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulataChun-Hwei Tai, Thomas Boraud, Erwan Bezard, et al.
Biomolecules|March 7, 2020
Targeting α-synuclein for PD Therapeutics: A Pursuit on All FrontsMargaux Teil, Marie-Laure Arotcarena, Emilie Faggiani, et al.
Bioanalysis|August 16, 2016
LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brainRené Fuertig, Angelo Ceci, Sandrine M Camus, et al.
Neurochemistry International|November 7, 2003
High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmissionWassilios Meissner, Daniel Harnack, Nora Hoessle, et al.
Scientific Reports|March 23, 2025
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.
Animal Models and Experimental Medicine|March 21, 2019
Microdialysis in awake macaque monkeys for central nervous system pharmacokineticsThibaud Thiollier, Caisheng Wu, Gregory Porras, et al.
European Journal of Pharmacology|November 19, 2003
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's diseaseOlivier Guillin, Nathalie Griffon, Erwan Bezard, et al.
Frontiers in Neuroscience|February 16, 2017
Exosomes, an Unmasked Culprit in Neurodegenerative DiseasesFederico N Soria, Olatz Pampliega, Mathieu Bourdenx, et al.
Neurobiology of Disease|September 4, 2012
Reinforcing properties of Pramipexole in normal and parkinsonian ratsMichel Engeln, Serge H Ahmed, Caroline Vouillac, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2009
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesiaAmandine Berthet, Grégory Porras, Evelyne Doudnikoff, et al.
Pageof 30

Showing results (91-100 of 298) with videos related to

Sort By:
Pageof 30
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 2, 2003
Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulataChun-Hwei Tai, Thomas Boraud, Erwan Bezard, et al.
Biomolecules|March 7, 2020
Targeting α-synuclein for PD Therapeutics: A Pursuit on All FrontsMargaux Teil, Marie-Laure Arotcarena, Emilie Faggiani, et al.
Bioanalysis|August 16, 2016
LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brainRené Fuertig, Angelo Ceci, Sandrine M Camus, et al.
Neurochemistry International|November 7, 2003
High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmissionWassilios Meissner, Daniel Harnack, Nora Hoessle, et al.
Scientific Reports|March 23, 2025
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.
Animal Models and Experimental Medicine|March 21, 2019
Microdialysis in awake macaque monkeys for central nervous system pharmacokineticsThibaud Thiollier, Caisheng Wu, Gregory Porras, et al.
European Journal of Pharmacology|November 19, 2003
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's diseaseOlivier Guillin, Nathalie Griffon, Erwan Bezard, et al.
Frontiers in Neuroscience|February 16, 2017
Exosomes, an Unmasked Culprit in Neurodegenerative DiseasesFederico N Soria, Olatz Pampliega, Mathieu Bourdenx, et al.
Neurobiology of Disease|September 4, 2012
Reinforcing properties of Pramipexole in normal and parkinsonian ratsMichel Engeln, Serge H Ahmed, Caroline Vouillac, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2009
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesiaAmandine Berthet, Grégory Porras, Evelyne Doudnikoff, et al.
Pageof 30